Blog

Miastenia grave

Myasthenia Gravis Stages: From Eye Muscle Weakness to Generalized Symptoms

Nurse explaining myasthenia gravis stages to patient

Miastenia gravis (MG) is an autoimmune neuromuscular disorder that causes muscle weakness and rapid fatigue in the voluntary muscles (muscles we can move and control, such as the eye muscles). Myasthenia gravis has a sudden onset, and its symptoms may change and progress over time, affecting different body parts. 

Hable con un especialista sobre la asistencia con los copagos

(877) 778-0318

Based on the symptoms and the type of muscles affected, myasthenia gravis is classified into five stages — ranging from mild to severe. Since each stage responds differently to treatment, a thorough diagnosis is required for effective patient treatment outcomes. 

This article discusses the five stages (classes) of myasthenia gravis that can help you identify the condition and seek medical attention in time. 

The Five Stages of Myasthenia Gravis

Healthcare providers classify the stages of myasthenia gravis based on the symptoms and the extent of the weakness an individual is experiencing. 

Early Stage: Class I

In the early stage, MG affects your eye muscles — in particular, the ocular muscles that control the movement of your eyes. Therefore, your eyelids become slightly weaker. This initial stage is called ocular myasthenia gravis since muscle weakness is only limited to the eyes. 

During this stage, an individual may experience the following symptoms:

  • Ptosis (drooping of eyelids)
  • Diplopia (double vision) 
  • Trouble focusing

Around 85% of patients experience ptosis or diplopia as a first symptom of myasthenia gravis. These symptoms may fluctuate, such as becoming more pronounced with fatigue and improving with rest. 

Since MG is difficult to diagnose in its early stages, a doctor may misdiagnose your ailment, believing the symptoms to be related to eye problems. 

Mild Stage Myasthenia Gravis: Class II

MG may affect other muscle groups beyond the eyes during the first two years of onset. For instance, muscles that control facial expressions can become weaker, and as a result, people experience difficulty in smiling. However, the symptom’s severity remains relatively mild during this stage. 

Generalized Myasthenia Gravis: Class III – V

Nurse talking to patient

Ocular myasthenia gravis often progresses to generalized myasthenia gravis within a year of onset if not diagnosed and treated earlier. In generalized myasthenia gravis, muscle weakness spreads to other parts of your body, such as the head and neck. 

The muscles surrounding the head and neck are called bulbar muscles. They are involved in speaking, swallowing, chewing, and holding the jaw in place. 

Around 15% of patients experience bulbar muscle weakness as an initial symptom. Symptoms include:

  • Difficulty chewing or frequent choking
  • Dysphagia (difficulty swallowing)
  • Hoarseness (changes in pitch and quality of the voice)
  • Dysarthria (difficulty speaking)
  • Dropped-head syndrome

The severity of the symptoms remains relatively moderate during this stage. Furthermore, the classes III – V in generalized myasthenia gravis are further categorized based on the severity and extent of muscle involvement.

4. Myasthenia Gravis Stage: Class IV

In stage IV, muscle weakness in the upper limbs becomes more pronounced than in the lower limbs. Patients struggle to do everyday tasks such as gripping or lifting objects, climbing stairs, walking, and sitting up. 

Muscle weakness may reach maximum severity within one to three years of onset in most people. However, with proper treatment, people can remain physically active. 

Obtenga asistencia financiera

Programar una consulta

 

5. Myasthenic Crisis: Class V

Class V is the severe stage of myasthenia gravis, also known as myasthenic crisis. In this stage, muscle weakness in the respiratory system causes difficulty breathing. The muscles that control breathing become severely weak and unable to perform properly.
This is a serious, life-threatening stage and requires immediate medical care, such as intubation or mechanical ventilation to maintain the airway. 
 

Conclusión

Myasthenia gravis (MG) is a long-term but rare neuromuscular disorder, causing muscle weakness in different parts of your body —  ranging from the eyes (ocular myasthenia gravis) to respiratory failure (severe stage). Understanding the stages of myasthenia gravis and the affected muscles can help you receive timely treatment. 

REFERENCIAS:

  1. Suresh, A. B., & Asuncion, R. M. D. (2023b). Miastenia gravis. StatPearls – NCBI Bookshelf. https://www.ncbi.nlm.nih.gov/books/NBK559331/
  2. Myasthenia Gravis Clinical Overview | MGFA. https://myasthenia.org/Professionals/Clinical-Overview-of-MG
  3. Hehir, M. K., & Silvestri, N. J. (2018). Generalized myasthenia gravis. Neurologic Clinics, 36(2), 253–260. https://doi.org/10.1016/j.ncl.2018.01.002
  4. Professional, C. C. M. Myasthenia gravis (MG). Cleveland Clinic. https://my.clevelandclinic.org/health/diseases/17252-myasthenia-gravis-mg
  5. Gilhus, N. E., & Verschuuren, J. J. (2015). Myasthenia gravis: subgroup classification and therapeutic strategies. Lancet Neurology, 14(10), 1023–1036. https://doi.org/10.1016/s1474-4422(15)00145-3
Esta información no sustituye el consejo ni el tratamiento médico. Consulte a su médico o profesional de la salud sobre su afección médica antes de comenzar cualquier tratamiento nuevo. AmeriPharma® Specialty Care no asume ninguna responsabilidad por la información proporcionada ni por ningún diagnóstico o tratamiento realizado como resultado, ni se responsabiliza de la fiabilidad del contenido. AmeriPharma® Specialty Care no opera todos los sitios web/organizaciones aquí mencionados, ni se responsabiliza de la disponibilidad o fiabilidad de su contenido. Estos listados no implican ni constituyen un respaldo, patrocinio ni recomendación por parte de AmeriPharma® Specialty Care. Esta página web puede contener referencias a medicamentos recetados de marca que son marcas comerciales o marcas registradas de fabricantes farmacéuticos no afiliados a AmeriPharma® Specialty Care.
Dr. Mark Alfonso
REVISADO MÉDICAMENTE POR Dr. Mark Alfonso, PharmD, BCMTMS

Dr. Mark Alfonso, PharmD was born and raised in Pueblo, CO. He received his pharmacy degree from the University of Colorado School of Pharmacy at the Anschutz Medical Campus in 2010. He was board certified in medication therapy management in 2022. The most rewarding part of his job is helping to answer patient questions and concerns. His areas of expertise are community pharmacy and medication therapy management. In his free time, he enjoys reading and running.

Contáctenos

Utilice el formulario HIPAA a continuación para solicitar la renovación de su receta. Si tiene alguna pregunta sobre su medicamento o cómo administrarlo, visite la página Contáctenos o llámenos al (877) 778-0318.

HIPAA Compliant

Al enviar, acepta los términos y condiciones de AmeriPharma. Condiciones de uso, política de privacidad, y Aviso de prácticas de privacidad

es_MXSpanish